Author

Fredrick O. Olewe

Observed names: Fredrick Olewe, Olewe, Fredrick

Institutions: Moi University, Strathmore University

Observed institutions: Moi University, Strathmore University, Kenya Medical Research Institute, KEMRI-Wellcome Trust Research Programme

ORCID: 0009-0006-9133-2060

Observed ORCID: 0009-0006-9133-2060

OpenAlex ID: A5017012284

A randomized, double-blind, phase 2b study to investigate the efficacy, safety, tolerability and pharmacokinetics of a single-dose regimen of ferroquine with artefenomel in adults and children with uncomplicated Plasmodium falciparum malaria

2021 · Yeka Adoke, Rella Zoleko-Manego, et al. · Malaria Journal · 56

Assessing the safety, impact and effectiveness of RTS,S/AS01E malaria vaccine following its introduction in three sub-Saharan African countries: methodological approaches and study set-up

2022 · Nicolas Praet, Kwaku Poku Asante, et al. · Malaria Journal · 39

Anti-merozoite antibodies induce natural killer cell effector function and are associated with immunity against malaria

2023 · Dennis O. Odera, James Tuju, et al. · Science Translational Medicine · 33

Phagocytosis of Plasmodium falciparum ring-stage parasites predicts protection against malaria

2022 · Fauzia K. Musasia, Irene N. Nkumama, et al. · Nature Communications · 27

Controlled human malaria infection (CHMI) outcomes in Kenyan adults is associated with prior history of malaria exposure and anti-schizont antibody response

2022 · Melissa C. Kapulu, Domtila Kimani, et al. · BMC Infectious Diseases · 25

Understanding the benefits and burdens associated with a malaria human infection study in Kenya: experiences of study volunteers and other stakeholders

2021 · Primus Che Chi, Esther Awuor Owino, et al. · Trials · 19

Effectiveness of the RTS,S/AS01E malaria vaccine in a real-world setting over 1 year of follow-up after the three-dose primary schedule: an interim analysis of a phase 4 study in Ghana, Kenya, and Malawi

2025 · Latif Ndeketa, Valérie Haine, et al. · The Lancet Global Health · 12

Safety of RTS,S/AS01E malaria vaccine up to 1 year after the third dose in Ghana, Kenya, and Malawi (EPI-MAL-003): a phase 4 cohort event monitoring study

2025 · Valérie Haine, Martina Oneko, et al. · The Lancet Global Health · 8

Lung function among children and adolescents with sickle cell disease living in Lake Victoria basin in Kenya

2026 · Fredrick O. Olewe, Constance N. Tenge, et al. · Frontiers in Pediatrics · 1

Pediatric Participant Retention Rates in a Longitudinal Malaria Immunology Study

2022 · Anushay Mistry, Boaz Odwar, et al. · American Journal of Tropical Medicine and Hygiene · 1

Antibodies targeting blood stage antigens of Plasmodium falciparum are associated with resistance to malaria infection and disease

2026 · Sangshin Park, Sunthorn Pond-tor, et al. · Clinical Infectious Diseases

Baseline Treg frequency, Treg-associated immune checkpoint responses, and plasma IL-10 responses during controlled human malaria infection in semi-immune Kenyan adults: a secondary analysis of the CHMI-SIKA Study

2026 · Kelvin M Kimenyi, Richard Morter, et al. · The Lancet Microbe

Controlled human malaria infection in adults identify combinations of merozoite antigens associated with clinical immunity

2026 · Rodney Ogwang, Irene N. Nkumama, et al. · Nature Communications

Lung functions among children and adolescents with sickle cell disease receiving care at Jaramogi Oginga Odinga Teaching and Referral Hospital Kisumu, Kenya

2024 · Fredrick O. Olewe, Constance N. Tenge, et al. · medRxiv

Works count: 23

Citation count: 225

H-index: 8

I10-index: 7